TRANSCAT INC (TRNS)
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TRNS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TRNS | Senior Vice President of Finance | 54 | ["Senior Vice President of Finance at Gilead Sciences", "More than two decades of US and international life science industry experience", "Experience in both biotech and large pharma", "Held financial executive leadership positions at Bristol Myers Squibb", "Technology & risk management consultant at Arthur Andersen LLP", "MBA with a concentration in finance from The Wharton School of the University of Pennsylvania", "Bachelor's in accounting from Loyola University in Maryland", "more than 25 years of financial experience in the life sciences industry", "expertise in financial management", "strategy development", "business expansion", "M&A", "experience leading organizations through stages of growth and transformation"] | ["AC"] | 2025 |
Biography sourced from the proxy statement filing.
Mr. Mecca is the Senior Vice President of Finance at Gilead Sciences, Inc. (Nasdaq: GILD), a leader in the life sciences industry. Mr. Mecca brings more than two decades of US and international life science industry experience in both biotech and large pharma. From July 2021 to July 2023, Mr. Mecca served as Senior Vice President of Finance at BeiGene USA (BeiGene), an oncology biotechnology company. Prior to his time at BeiGene, Mr. Mecca was Senior Vice President of Commercialization Finance at Bristol Myers Squibb, a global pharmaceutical company, where he held a series of expanding financial executive leadership positions with responsibilities for global manufacturing, international commercialization, R&D and business development. Mr. Mecca started his career as a technology & risk management consultant at Arthur Andersen LLP, an accounting firm. Mr. Mecca earned a master of business administration with a concentration in finance from The Wharton School of the University of Pennsylvania and a bachelor of administration in accounting from Loyola University in Maryland. Mr. Mecca served on the board of directors of the Emmanuel Cancer Foundation from June 2018 through December 2024.